Transformative health policies for NCDs: Emphasizing the importance of an integrated approach for cardiorenal conditions
This event, produced by Devex, organized and funded by AstraZeneca and Boehringer Ingelheim and in partnership with the International Society of Nephrology and the Global Patient Alliance for Kidney Health – will deep-dive into the challenges and opportunities surrounding cardiovascular, renal and metabolic conditions, including the urgent need for global recognition of their close interconnections and for prioritizing their care.
We’ll be joined by a diverse group of experts – including healthcare professionals, policymakers, patient organizations, and representatives from multilateral organizations – to explore how global health platforms can help advocate for early detection and integrated care models for cardiovascular, renal and metabolic conditions, with a particular focus on chronic kidney disease (CKD). CKD is one of the leading causes of morbidity and mortality, impacting millions worldwide. Despite its significant prevalence, it often remains overlooked in global health agendas.
Among others, you’ll hear from Valerie Luyckx, chair of advocacy working group at the International Society of Nephrology, who will be interviewed by Hannah Vaughan Jones, broadcaster and journalist, at Lewnah Ltd.
We hope you can join us on Sept. 25 from 3-4 p.m. EST, with lunch from 2:25-3:00 p.m. To confirm your attendance, please register to join us in person in New York or online for the live broadcast below.